These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26334182)

  • 1. Depression and hypomania symptoms are associated with high dose corticosteroids treatment for MS relapses.
    Morrow SA; Barr J; Rosehart H; Ulch S
    J Affect Disord; 2015 Nov; 187():142-6. PubMed ID: 26334182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulse steroid therapy in multiple sclerosis and mood changes: An exploratory prospective study.
    Lorefice L; Fenu G; Fois M; Frau J; Coghe G; Marrosu MG; Cocco E
    Mult Scler Relat Disord; 2018 Feb; 20():104-108. PubMed ID: 29360061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Mood Disorder Questionnaire (MDQ) for detecting (hypo)manic episodes: its validity and impact of recall bias.
    Boschloo L; Nolen WA; Spijker AT; Hoencamp E; Kupka R; Penninx BW; Schoevers RA
    J Affect Disord; 2013 Oct; 151(1):203-8. PubMed ID: 23790555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anxiety comorbidity in bipolar spectrum disorders: the mediational role of perfectionism in prospective depressive symptoms.
    O'Garro-Moore JK; Adams AM; Abramson LY; Alloy LB
    J Affect Disord; 2015 Mar; 174():180-7. PubMed ID: 25499686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral fingolimod (FTY720) in relapsing multiple sclerosis: impact on health-related quality of life in a phase II study.
    Montalban X; Comi G; O'Connor P; Gold S; de Vera A; Eckert B; Kappos L
    Mult Scler; 2011 Nov; 17(11):1341-50. PubMed ID: 21727148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant-associated mania or hypomania: a comparison with personality and bipolarity features of bipolar I disorder.
    Saatcioglu O; Erim R; Tomruk N; Oral T; Alpay N
    J Affect Disord; 2011 Nov; 134(1-3):85-90. PubMed ID: 21632117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and humanistic impact of potential misdiagnosis of bipolar disorder among patients with major depressive disorder in a commercially insured population.
    Kamat SA; Rajagopalan K; Pethick N; Willey V; Bullano M; Hassan M
    J Manag Care Pharm; 2008 Sep; 14(7):631-42. PubMed ID: 18774873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-reported psychosis-like experiences in patients with mood disorders.
    Baryshnikov I; Suvisaari J; Aaltonen K; Koivisto M; Melartin T; Näätänen P; Suominen K; Karpov B; Heikkinen M; Oksanen J; Paunio T; Joffe G; Isometsä E
    Eur Psychiatry; 2018 Jun; 51():90-97. PubMed ID: 28797561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Child behavior checklist profiles in adolescents with bipolar and depressive disorders.
    Kweon K; Lee HJ; Park KJ; Joo Y; Kim HW
    Compr Psychiatry; 2016 Oct; 70():152-8. PubMed ID: 27624435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient education program to enhance decision autonomy in multiple sclerosis relapse management: a randomized-controlled trial.
    Köpke S; Kasper J; Mühlhauser I; Nübling M; Heesen C
    Mult Scler; 2009 Jan; 15(1):96-104. PubMed ID: 18845657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma exchange in severe acute relapses of multiple sclerosis - Results from a Portuguese cohort.
    Correia I; Ribeiro JJ; Isidoro L; Batista S; Nunes C; Macário C; Borges C; Tomaz J; Sousa L
    Mult Scler Relat Disord; 2018 Jan; 19():148-152. PubMed ID: 29241141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns and predictors of naturally occurring change in depressive symptoms over a 30-month period in multiple sclerosis.
    Ensari I; Motl RW; McAuley E; Mullen SP; Feinstein A
    Mult Scler; 2014 Apr; 20(5):602-9. PubMed ID: 24067897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are manic symptoms that 'dip' into depression the essence of mixed features?
    Malhi GS; Fritz K; Allwang C; Burston N; Cocks C; Devlin J; Harper M; Hoadley B; Kearney B; Klug P; Meagher L; Rowe M; Samir H; Way R; Wilson C; Lyndon W
    J Affect Disord; 2016 Mar; 192():104-8. PubMed ID: 26717522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of a switch to fingolimod on depressive symptoms in patients with relapsing multiple sclerosis: An analysis from the EPOC (Evaluate Patient OutComes) trial.
    Hunter SF; Agius M; Miller DM; Cutter G; Barbato L; McCague K; Meng X; Agashivala N; Chin P; Hollander E
    J Neurol Sci; 2016 Jun; 365():190-8. PubMed ID: 27206905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High dose oral steroids commonly used to treat relapses in Canadian MS clinics.
    Morrow SA; Metz LM; Kremenchutzky M
    Can J Neurol Sci; 2009 Mar; 36(2):213-5. PubMed ID: 19378717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bipolarity in depressive patients without histories of diagnosis of bipolar disorder and the use of the Mood Disorder Questionnaire for detecting bipolarity.
    Kim B; Wang HR; Son JI; Kim CY; Joo YH
    Compr Psychiatry; 2008; 49(5):469-75. PubMed ID: 18702932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross validation with the mood disorder questionnaire (MDQ) of an instrument for the detection of hypomania in Brazil: The 32 item hypomania symptom check-list, first Revision (HCI-32-R1).
    Leão IA; Del Porto JA
    J Affect Disord; 2012 Nov; 140(3):215-21. PubMed ID: 22284020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychiatric side effects of acute high-dose corticosteroid therapy in neurological conditions.
    Lotan I; Fireman L; Benninger F; Weizman A; Steiner I
    Int Clin Psychopharmacol; 2016 Jul; 31(4):224-31. PubMed ID: 26938038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined treatment with corticosteroids and moclobemide favors normalization of hypothalamo-pituitary-adrenal axis dysregulation in relapsing-remitting multiple sclerosis: a randomized, double blind trial.
    Then Bergh F; Kümpfel T; Grasser A; Rupprecht R; Holsboer F; Trenkwalder C
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1610-5. PubMed ID: 11297592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.